Ohio Attorney General Mike DeWine announced on Friday that Ohio is part of a legal settlement with a manufacturer of medical and surgical supplies and medical devices.
The settlement resolves civil allegations of unlawful marketing practices and the payment of kickbacks from CareFusionâ??s surgical prep solution, Chloraprep.
Under the terms of the settlement, CareFusion will pay $40.1 million to the states and the federal government listed as plaintiffs in the suit.
Ohio's will get $352,113 of the settlement from CareFusion.
"The investigation found that this company promoted and marketed the Chloraprep solution for uses that were not approved by the Food and Drug Administration, which is very dangerous." said Attorney General DeWine. "Had those using the solution known the facts, they likely would have chosen a safer alternative instead."
Chloraprep was approved by the FDA for specific inpatient hospital procedures, including the preparation of a patientâ??s skin prior to surgery or injection, but the FDA explicitly rejected its use for intravenous preparation and suture care.
The lawsuit alleges that during the period between September 1, 2009 and August 31, 2011, CareFusion promoted Chloraprep for use with intravenous preparation and suture care, which went beyond the FDA-approved label uses for Chloraprep.
More details on the settlement are explained on the
Ohio Attorney General's website